Clinical Trials Logo
  1. Home
  2. Uncontrolled Hypertension
  3. NCT03209154
  4. Details
NCT03209154 Clinical Trial

An Interventional Multidisciplinary Approach to Individualize Blood Pressure Treatment

Uncontrolled Hypertension Clinical Trial

— IDA  

Official title:
Individualized Blood Pressure Treatment: a Multidisciplinary Approach to Uncontrolled Hypertension in Order to Reduce Morbidity and Mortality

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT03209154
Other study ID # 2017/6534
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date April 30, 2025

Study information
Verified date November 2023
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to investigate and explore the most important aspects of drug-adherence in the treatment of hypertension in order to improve treatment and blood pressure control, implying that new knowledge will reduce morbidity and mortality.

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 1000
Est. completion date April 30, 2025
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Signed informed consent - Uncontrolled hypertension - A stable medication regimen for at least 4 weeks of = 2 antihypertensive agents - No planned changes in antihypertensive drugs Exclusion Criteria: - Withdrawal of consent - 24-h systolic ambulatory blood pressure >/= 170 mmHg - Patients with inadequate Norwegian language skills - Positive pregnancy test - Known alcohol or drug abuse - estimated glomerular filtration rate <30 mL/min/1.73m2 - Albumin/creatinin ratio >300 mg/mmol - Any reason why, in the opinion of the investigator, the patient should not participate

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Therapeutic drug monitoring
Therapeutic drug monitoring will be performed.
Device:
• Home blood pressure monitoring
Patients will perform home blood pressure monitoring at home.

Locations
Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (5)
Lead Sponsor Collaborator
Oslo University Hospital Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway, University of Oslo

Country where clinical trial is conducted

Norway, 

Outcome
Type Measure Description Time frame Safety issue
Primary Blood pressure control Change in systolic daytime ambulatory blood pressure. 3 months after baseline
See also
  Status Clinical Trial Phase
Withdrawn NCT01939392 - Rapid Renal Sympathetic Denervation for Resistant Hypertension II Phase 2/Phase 3
Terminated NCT01966952 - Evaluation of Safety Mechanisms of Renal Radioablation(RSRA)for Uncontrolled Hypertension N/A
Completed NCT01699529 - Multi-electrode Radiofrequency Renal Denervation System Feasibility Study N/A
Completed NCT01418261 - SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension N/A
Completed NCT01635998 - Adjunctive Renal Denervation in the Treatment of Atrial Fibrillation N/A
Completed NCT02674464 - Reducing Inequities in Care of Hypertension, Lifestyle Improvement for Everyone (RICH LIFE Project) N/A
Completed NCT04809519 - Integrative Nursing Based Multimodal Interventions for Uncontrolled Hypertensives N/A
Completed NCT01996033 - EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
Terminated NCT01628198 - Impact of Renal SympAthetic DenerVation on Chronic HypErtension N/A
Recruiting NCT03221114 - Positive Psychology Intervention for Spanish-speaking Hispanic/Latino Adults at Risk for Cardiovascular Disease N/A
Completed NCT04248530 - DENEX Renal Denervation in Patients With Uncontrolled Hypertension: Safety Study N/A
Recruiting NCT06034743 - A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension Phase 3
Completed NCT02006758 - Observational Study of the EnligHTN Renal Denervation System in Europe
Withdrawn NCT05352425 - Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension N/A
Not yet recruiting NCT06336356 - A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension Phase 2
Completed NCT05395403 - Use of Automated Office Blood Pressure Monitoring N/A
Recruiting NCT05732727 - Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease Phase 3
Completed NCT02418091 - Integrated Population Program for Diabetic Kidney Disease N/A
Not yet recruiting NCT05234788 - Renal Artery DenervatIon Using Radial accesS in Uncontrolled HyperTensioN N/A
Completed NCT00888433 - Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) N/A